Updated Results Confirm Aldoxorubicin Superiority in STS
Andrew J. Roth
Published Online: Thursday, December 19, 2013
Aldoxorubicin demonstrated significant benefit to progression-free survival (PFS) compared with doxorubicin in patients with first-line, metastatic, locally advanced or unresectable soft tissue sarcomas (STS), according to the results of an international phase IIb trial.
Both the investigator analysis and blinded central laboratory review showed an 80%-100% improvement in STS patients treated with aldoxorubicin. In the investigator analysis, median PFS was 8.4 months in the aldoxorubicin arm compared with 4.7 months in the doxorubicin arm (P = .0002). The blinded review showed that median PFS in the aldoxorubicin arm was 5.7 months compared with 2.8 months in the doxorubicin arm (P = .018).
- - - - - - -
Stratasys Fused Deposition Modeling (FDM)
Working with ORNL to develop process monitoring and closed loop feedback control systems to increase the mechanical properties and production quality of fused deposition modeling (FDM)
If fungiforu's "I have read on many occasions where they Sigma said it will be functional in 2011, 2012, and 2013" is true", then their Management is a VERY POOR MANAGEMENT!
All the above (I copied it bellow) is great. But WHEN will it be done????????????
No word about deadlines, or commercialization deadlines. I understand "undercover", but this time is to be public. Their NASA and defense experience is very good, but as Management in the industrial competition they stinks.
Big guys brought the stock at 0.21, and wait. We don't count, and Mr. Cola keeps thinking.
Like Anderson's "Next step 0.30 - 0.32".
There is no "sure thing" in this business. Just probabilities. Get down to Earth.
Before Aug. 14 there was no "commercialization" wordign from SGLB. After that date the charts went up, being a different stage of the company. Today's charts should have no connection with anything before Aug. 14.
smallcapthinkingcap, what are the parameters values to get the BBands you described?
And if you have one (or a couple of) preferred sites for charting?
My SGLB chart is stuck for 1 hour (Ask 0.20, Bid 0.20). Do you have the same thing?
Do you know how to make a real/good chart? By charts, today's up could have come yesterday, today or tomorrow. If you are SO OUT OF TOUCH WITH CHARTING AND ALL THE OTHER TECHNIQUES, why don't go for another hobby? Or, borrow some brain, eat correctly (too late), and do'nt drink too much.
It's just that "hated" chart/trend/distance_to_support. Don't think you have anything else serious.
The reality is that most SGLB buyers sell only a small part of it. Most of the stock is kept.
Don't know about any burns of mine, but yours are All Written on you: "Sunbreast1".
They're your nature.
Anderson thought that if he sells AMAVF and pumps up SGLB, the market will push SGLB even upper. The hedge funds guys red it, played it, and burned Anderson (and some of us, too).
Anderson, you believe that if you speak Swedish, you are better than anybody. You were proved wrong. Neither you, nor us can be better than a big fund. This is one of the market laws. Long run - yes, but short run - hell no! Look at what happened today, after you announced that you sold AMAVF and bought SGLB. From our point of view, when you translate from Swedish - it is good, when you try to "talk the markets" - it is bad. Please, keep your opinions for you! Thank you.
Thank you Rakesh.
Now, I observe that your 120 million is the same number as in the "private placement of 120,000,000 shares of the Company's common stock, $0.001 par value per sharestock, on July 18". So, are we talking about the same shares (were the 120 million shares given as restricted stock for 6 months, so till Jan. 18?
ThanxRakesh for your help.
What is that "release of shares", please?
What seems to be similar (as a number) is "On July 18, 2013, Sigma Labs, Inc. (the "Company"), completed a private placement of 120,000,000 shares of the Company's common stock, $0.001 par value per share, for an aggregate offering price of $1,200,000. The shares were sold solely to accredited investors."
So what will be/happen (in reality, not shorts imagination) on Jan 14 or 18, please?